硕世生物(688399)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688399 硕世生物

已收盘 05-09 15:00:00

{"stockData":{"symbol":"688399","market":"SH","secType":"STK","nameCN":"硕世生物","latestPrice":64.82,"timestamp":1746774000000,"preClose":66.9,"halted":0,"volume":526007,"delay":0,"changeRate":-0.0311,"floatShares":56670100,"shares":56670100,"eps":-0.5162,"marketStatus":"已收盘","change":-2.08,"latestTime":"05-09 15:00:00","open":67.1,"high":67.24,"low":64.82,"amount":34594500,"amplitude":0.0362,"askPrice":65.03,"askSize":24,"bidPrice":64.82,"bidSize":3,"shortable":0,"etf":0,"ttmEps":-0.5162,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747013400000},"marketStatusCode":5,"adr":0,"adjPreClose":66.9,"symbolType":"stock_kcb","openAndCloseTimeList":[[1746754200000,1746761400000],[1746766800000,1746774000000]],"highLimit":73.59,"lowLimit":60.21,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":56670082,"isCdr":false,"pbRate":1.13,"roa":"--","roe":"0.39%","epsLYR":-0.03,"committee":0.192661,"marketValue":3673000000,"turnoverRate":0.0093,"status":1,"afterMarket":{"amount":0,"volume":0,"close":64.82,"buyVolume":1500,"sellVolume":0,"time":1746776038029,"indexStatus":"已收盘 05-09 15:30:00","preClose":66.9},"floatMarketCap":3673000000},"requestUrl":"/m/hq/s/688399","defaultTab":"news","newsList":[{"id":"2534797751","title":"硕世生物05月09日遭主力抛售91.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534797751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534797751?lang=zh_cn&edition=full","pubTime":"2025-05-09 15:20","pubTimestamp":1746775246,"startTime":"0","endTime":"0","summary":"05月09日, 硕世生物股价跌3.11%，报收64.82元，成交金额3459.4万元，换手率0.93%，振幅3.62%，量比1.16。硕世生物今日主力资金净流出91.5万元，上一交易日主力净流出277.5万元。|05月09日主力加仓幅度排名||#|股票简称|主力净额占比|#|中国瑞林|10.75%|#|星德胜|9.03%|#|科蓝软件|6.29%|#|...|...|#2281|硕世生物|-0.02%|硕世生物所在的医疗器械行业，今日主力净流出1.76亿元，行业排名58/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509172104a477ee15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509172104a477ee15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688399","BK0239"],"gpt_icon":0},{"id":"2533570092","title":"硕世生物：公司控股股东股权结构发生变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2533570092","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533570092?lang=zh_cn&edition=full","pubTime":"2025-05-06 17:20","pubTimestamp":1746523245,"startTime":"0","endTime":"0","summary":"格隆汇5月6日丨硕世生物(688399.SH)公布，近期，泰州硕越股权投资合伙企业（有限合伙）（简称“泰州硕越”）与南京高科新浚成长一期股权投资合伙企业（有限合伙）（简称“高科新浚”）签署《绍兴闰康生物医药股权投资合伙企业（有限合伙）合伙份额转让协议》，高科新浚将其所持闰康生物13.0833%的股权转让给泰州硕越。上述变动未导致公司控股股东及实际控制人发生变更，公司控股股东仍为闰康生物、实际控制人仍为房永生、梁锡林与王国强。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050617204597507d12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050617204597507d12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688399","BK0239"],"gpt_icon":0},{"id":"2532018937","title":"硕世生物（688399）2025年一季报简析：增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2532018937","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532018937?lang=zh_cn&edition=full","pubTime":"2025-05-01 06:41","pubTimestamp":1746052870,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期硕世生物发布2025年一季报。根据财报显示，硕世生物增收不增利。截至本报告期末，公司营业总收入9160.84万元，同比上升0.54%，归母净利润1281.94万元，同比下降68.01%。本次财报公布的各项数据指标表现一般。分析师工具显示：证券研究员普遍预期2025年业绩在2000.0万元，每股收益均值在0.35元。持有硕世生物最多的基金为鑫元专精特新混合A，目前规模为0.91亿元，最新净值0.5363，较上一交易日上涨0.06%，近一年上涨4.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050100004857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"gpt_icon":0},{"id":"2531789272","title":"图解硕世生物一季报：第一季度单季净利润同比减68.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531789272","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531789272?lang=zh_cn&edition=full","pubTime":"2025-04-29 19:18","pubTimestamp":1745925513,"startTime":"0","endTime":"0","summary":"证券之星消息，硕世生物2025年一季报显示，公司主营收入9160.84万元，同比上升0.54%；归母净利润1281.94万元，同比下降68.01%；扣非净利润-558.05万元，同比下降137.52%；负债率15.66%，投资收益146.01万元，财务费用-221.79万元，毛利率57.93%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900037174.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399"],"gpt_icon":0},{"id":"2531620707","title":"硕世生物：2025年第一季度计提减值准备59.06万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531620707","media":"公司公告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531620707?lang=zh_cn&edition=full","pubTime":"2025-04-29 17:16","pubTimestamp":1745918181,"startTime":"0","endTime":"0","summary":"硕世生物公告，2025年第一季度计提信用减值及资产减值准备合计59.06万元，计入减值损失金额-318.29万元，增加利润总额318.29万元。公司基于会计谨慎性原则作出判断，董事会、监事会均认为符合企业会计准则及相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429181449a6cd18f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429181449a6cd18f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688399"],"gpt_icon":0},{"id":"2530905459","title":"硕世生物04月25日遭主力抛售149万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530905459","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530905459?lang=zh_cn&edition=full","pubTime":"2025-04-25 15:22","pubTimestamp":1745565740,"startTime":"0","endTime":"0","summary":"04月25日, 硕世生物股价跌2.62%，报收65.00元，成交金额1901万元，换手率0.51%，振幅2.64%，量比0.63。硕世生物今日主力资金净流出149万元，连续3日净流出，上一交易日主力净流出79万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为68.00%，平均跌幅为1.59%。|04月25日主力加仓幅度排名||#|股票简称|主力净额占比|#|N众捷汽车|25.80%|#|天元智能|12.79%|#|九洲集团|10.34%|#|...|...|#3315|硕世生物|-0.04%|硕世生物所在的医疗器械行业，今日主力净流出2.13亿元，行业排名20/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425163501a46687fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425163501a46687fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688399","BK0239"],"gpt_icon":0},{"id":"2529360507","title":"硕世生物04月24日遭主力抛售79万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529360507","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529360507?lang=zh_cn&edition=full","pubTime":"2025-04-24 15:21","pubTimestamp":1745479289,"startTime":"0","endTime":"0","summary":"04月24日, 硕世生物股价跌0.88%，报收66.75元，成交金额3842万元，换手率1.03%，振幅4.56%，量比1.47。硕世生物今日主力资金净流出79万元，上一交易日主力净流出504万元。该股近5个交易日上涨0.50%，主力资金累计净流出459万元；近20日主力资金累计净流出4031万元，其中净流出天数为13日。|04月24日主力加仓幅度排名||#|股票简称|主力净额占比|#|N天有|22.97%|#|N江顺科技|15.83%|#|金凯生科|7.71%|#|...|...|#2310|硕世生物|-0.02%|硕世生物所在的医疗器械行业，今日主力净流出3.33亿元，行业排名35/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424162140a465087b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424162140a465087b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688399","BK0239"],"gpt_icon":0},{"id":"2528855276","title":"硕世生物2024年营收3.5亿元下降13.3%，净亏减至200万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528855276","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528855276?lang=zh_cn&edition=full","pubTime":"2025-04-20 15:05","pubTimestamp":1745132727,"startTime":"0","endTime":"0","summary":"4月18日，硕世生物公布2024年年报，公司营业收入为3.5亿元，同比下降13.3%；归母净利润自去年同期亏损3.74亿元变为亏损200万元，亏损额有所减少；扣非归母净利润自去年同期亏损4.29亿元变为亏损7184万元，亏损额有所减少；经营现金流净额为1.46亿元，同比增长229.0%；EPS为-0.0353元。截至四季度末，公司总资产37.4亿元，较上年度末下降4.3%；归母净资产为32.51亿元，较上年度末下降4.5%。报告期内，公司的营业收入为3.5亿元，同比下降13.3%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250420150612973e259d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250420150612973e259d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688399"],"gpt_icon":0},{"id":"2528840788","title":"硕世生物（688399）2024年年报简析：亏损收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2528840788","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528840788?lang=zh_cn&edition=full","pubTime":"2025-04-20 06:07","pubTimestamp":1745100458,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期硕世生物发布2024年年报。根据财报显示，硕世生物亏损收窄。截至本报告期末，公司营业总收入3.5亿元，同比下降13.29%，归母净利润-200.17万元，同比上升99.46%。本次财报公布的各项数据指标表现一般。财务费用变动幅度为30.87%,原因:利息收入减少。经营活动产生的现金流量净额变动幅度为228.97%,原因:当期采购款支出、人工成本支出、税费支出减少。合同负债变动幅度为168.02%,原因:预收货款增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042000000523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"gpt_icon":0},{"id":"2528049553","title":"每周股票复盘：硕世生物（688399）2024年年报主营收入3.5亿元，同比下降13.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528049553","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528049553?lang=zh_cn&edition=full","pubTime":"2025-04-19 08:03","pubTimestamp":1745020989,"startTime":"0","endTime":"0","summary":"截至2025年4月18日收盘，硕世生物报收于65.0元，较上周的66.4元下跌2.11%。本周，硕世生物4月16日盘中最高价报68.63元。本周关注点业绩披露要点：2024年年报显示，公司主营收入3.5亿元，同比下降13.29%业绩披露要点：归母净利润-200.17万元，同比上升99.46%业绩披露要点：2024年第四季度单季度主营收入8152.09万元，同比下降35.68%业绩披露要点硕世生物2024年年报显示，公司主营收入3.5亿元，同比下降13.29%；归母净利润-200.17万元，同比上升99.46%；扣非净利润-7183.71万元，同比上升83.26%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041900009259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399"],"gpt_icon":0},{"id":"2528098519","title":"硕世生物(688399.SH)发布2024年度业绩，归母净亏损200万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528098519","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528098519?lang=zh_cn&edition=full","pubTime":"2025-04-18 22:39","pubTimestamp":1744987170,"startTime":"0","endTime":"0","summary":"智通财经APP讯，硕世生物(688399.SH)披露2024年年度报告，报告期公司实现营收3.5亿元，同比下降13.29%;归母净利润亏损200万元，同比收窄;扣非净利润亏损7184万元，同比收窄;基本每股收益-0.03元。公司拟以实施权益分派股权登记日登记的总股本为基数转增股份，以公司上市时股票溢价发行形成的资本公积金向全体股东每10股转增4.8股，不派发现金红利，不送红股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1281044.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688399","BK0239"],"gpt_icon":0},{"id":"2518020483","title":"硕世生物获得实用新型专利授权：“试剂卡推送选择装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2518020483","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518020483?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:10","pubTimestamp":1741633836,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示硕世生物新获得一项实用新型专利授权，专利名为“试剂卡推送选择装置”，专利申请号为CN202520120426.4，授权日为2025年3月11日。本实用新型利用双层空间最大化减少机构的体积，解决了任意试剂卡卡槽内的试剂卡不能方便带入轨道的问题，达到多通道选择试剂卡进入特定轨道的效果。今年以来硕世生物新获得专利授权6个，较去年同期增加了200%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031100002260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"gpt_icon":0},{"id":"2517101606","title":"硕世生物：积极关注前沿技术发展审慎评估相关技术应用场景推进数字化转型","url":"https://stock-news.laohu8.com/highlight/detail?id=2517101606","media":"证星董秘互动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517101606?lang=zh_cn&edition=full","pubTime":"2025-03-07 17:30","pubTimestamp":1741339838,"startTime":"0","endTime":"0","summary":"证券之星消息，硕世生物03月07日在投资者关系平台上答复投资者关心的问题。公司接入DeepSeek有哪些成本、收益方面的考量？如果公司计划在未来再进行部署，计划将DeepSeek应用于什么具体的业务呢？公司秉持着创新驱动发展的理念，积极关注前沿技术的发展，并基于实际需求和技术适用性，审慎评估相关技术在公司运营和业务开展中的应用场景和合作可能性，加快推进数字化、智能化应用，深入推动公司数字化转型。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307173223963d47b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307173223963d47b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688399"],"gpt_icon":0},{"id":"2517137823","title":"基蛋输了！不准“悔婚”","url":"https://stock-news.laohu8.com/highlight/detail?id=2517137823","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517137823?lang=zh_cn&edition=full","pubTime":"2025-03-06 17:34","pubTimestamp":1741253640,"startTime":"0","endTime":"0","summary":"　　A股又见“悔婚”大战，主角是被投资人戏称为“不孵蛋”的基蛋生物和武汉景川诊断技术股份有限公司。　　2月26日晚间，基蛋生物与景川诊断的又一桩股权收购纠纷案迎来终审判决，基蛋生物最终被判支付股权收购款约3586.12万元。　　如今看来，基蛋生物显然无法“悔婚”，不过基蛋生物并没有就此罢休。　　值得注意的是，基蛋生物在2023年就出现了“业绩转折点”。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2025-03-06/doc-inenthxi3440774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0046","BK0197","BK0042","603387","688399","300482","688298"],"gpt_icon":0},{"id":"2516942276","title":"中国脑机接口行业发展与展望：医疗器械专题之脑机接口","url":"https://stock-news.laohu8.com/highlight/detail?id=2516942276","media":"华安证券股份有...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516942276?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:00","pubTimestamp":1741017600,"startTime":"0","endTime":"0","summary":"政策引导+技术突破，全球脑机接口产业进入高速发展阶段，中国非侵入式脑机接口技术全球领先。中国围绕非侵入式脑机接口方向，实现弯道超车，首创实现“双环路”脑机交互系统，打破了传统脑机接口的信息交互，并极大突破了操控时间的限制，该技术突破使得中国在非侵入式脑机接口领域处于全球领先地位。医疗健康是当前脑机接口最成熟的赛道，覆盖神经疾病诊断、康复治疗及功能替代。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304094553989abda6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304094553989abda6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600529","688393","688426","688576","605369","603658","688161","688151","688289","688013","688217","603880","688351","688029","688253","688366","600807","688575","688193","688298","BK0146","603987","688277","688338","688212","688317","688075","688068","688358","688410","688314","603309","688613","688271","688606","688468","603222","688139","600645","600055","688085","688399","688580","688301","688677","BK0251","688626","688236","688108","688273","603205","688016","688607","688767","688067","688617","BK0070","688389","159883","688026","603387","600587","688114","688581","688656","603976","603301","688050","BK0114","688198"],"gpt_icon":0},{"id":"2514357908","title":"公司深度报告：“产品+营销”双轮驱动，塑造家用医疗器械领先品牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2514357908","media":"信达证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514357908?lang=zh_cn&edition=full","pubTime":"2025-02-28 08:06","pubTimestamp":1740701178,"startTime":"0","endTime":"0","summary":"鱼跃医疗本期内容提要:核心观点：我们认为在人口老龄化的背景下，居民健康管理及家庭康养需求提升，家用医疗器械产品市场规模有望逐步扩大。公司作为国内领先的家用医疗器械厂商，随着产品管线逐步丰富，品牌影响力不断增强，市场份额有望不断提升，业务有望保持稳健增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022808062298957ecb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022808062298957ecb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603880","603976","688613","688236","603987","688212","688217","688029","688067","688273","688358","688393","603387","688399","688351","688161","688317","688580","688576","600055","688338","688085","603301","688301","688050","603205","688298","688389","688656","688617","688108","688606","688114","688198","688013","600587","688139","688277","688289","688575","688253","688426","688677","600645","BK0114","688626","603222","600807","BK0070","600529","159883","603658","688151","688068","605369","688075","688581","688410","BK0146","688767","688468","688314","BK0251","688193","688271","603309","688607","688366"],"gpt_icon":0},{"id":"2514687846","title":"硕世生物(688399.SH)2024年度净亏损206.59万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514687846","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514687846?lang=zh_cn&edition=full","pubTime":"2025-02-27 16:40","pubTimestamp":1740645600,"startTime":"0","endTime":"0","summary":"硕世生物(688399.SH)发布2024年度业绩快报，报告期内，公司实现营业总收入3.5亿元，同比下降13.28%;实现归属于母公司所有者净亏损206.59万元;实现归属于母公司所有者的扣除非经常性损益净亏损7,300.57万元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-02-27/doc-inemxmaf7846667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688399"],"gpt_icon":0},{"id":"2514827424","title":"硕世生物2024年度业绩快报：归母净利润约-207万元，同比减亏99.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514827424","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514827424?lang=zh_cn&edition=full","pubTime":"2025-02-27 16:29","pubTimestamp":1740644940,"startTime":"0","endTime":"0","summary":"2月27日，硕世生物发布公告，2024年度业绩快报显示，公司实现营业总收入3.5亿元，同比下降13.28%。归母净利润约-207万元，同比减亏99.45%;归母净利润（扣非后）约-7301万元，同比减亏82.99%。报告期末，公司总资产为37.38亿元，较期初减少4.31%；归母权益为32.49亿元，较期初减少4.6%。公司采取降本增效措施，期间费用大幅下降，相关减值损失也同比大幅下降，促进了利润的减亏表现。2024年前三季度，硕世生物实现收入2.68亿元，归母净利润2711万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227163319963246c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227163319963246c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688399"],"gpt_icon":0},{"id":"2514229508","title":"硕世生物发布2024年度业绩快报，亏损0.021亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514229508","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514229508?lang=zh_cn&edition=full","pubTime":"2025-02-27 16:27","pubTimestamp":1740644840,"startTime":"0","endTime":"0","summary":"证券之星消息，硕世生物近日即将发布2024年年报，根据2月27日发布的业绩快报，归属净利润亏损0.021亿元，同比增长99.45%。报告期末，公司总资产 373,806.61 万元，较本报告期初减少 4.31%；归属于母公司的所有者权益 324,858.09 万元，较本报告期初减少 4.60%；归属于母公司所有者的每股净资产 57.32元，较本报告期初减少 1.33%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022700027630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746805380958,"stockEarnings":[{"period":"1week","weight":0.0345},{"period":"1month","weight":0.0843},{"period":"3month","weight":0.0516},{"period":"6month","weight":-0.1745},{"period":"1year","weight":-0.1087},{"period":"ytd","weight":0.018}],"compareEarnings":[{"period":"1week","weight":0.0223},{"period":"1month","weight":0.0656},{"period":"3month","weight":0.0146},{"period":"6month","weight":-0.0291},{"period":"1year","weight":0.0714},{"period":"ytd","weight":0.0001}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏硕世生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"7753人(较上一季度减少1.40%)","perCapita":"7309股","listingDate":"2019-12-05","address":"江苏省泰州市海陵区药城大道837号","registeredCapital":"5667万元","survey":"　　江苏硕世生物科技股份有限公司的主营业务是体外诊断试剂、配套检测仪器等体外诊断产品的研发、生产和销售。公司的主要产品是核酸分子诊断试剂、核酸纯化试剂、免疫类诊断试剂、干化学诊断试剂、检测服务。公司已经连续7年参与三八公益活动并荣获“社会公益奖”，累计为过万名女性提供免费宫颈癌筛查服务。","listedPrice":46.78},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"硕世生物(688399)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供硕世生物(688399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"硕世生物,688399,硕世生物股票,硕世生物股票老虎,硕世生物股票老虎国际,硕世生物行情,硕世生物股票行情,硕世生物股价,硕世生物股市,硕世生物股票价格,硕世生物股票交易,硕世生物股票购买,硕世生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"硕世生物(688399)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供硕世生物(688399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}